Description / Myostatin-Propeptide
Mature Myostatin is obtained by proteolytic processing of a biologically-inactive precursor protein, which contains an N-terminal propeptide of 243 amino acid residues. Myostatin Propeptide exhibits high binding affinity for myostatin and has been shown to be a potent inhibitor of Myostatin. Over-expression of myostatin propeptide in mice resulted in large increases (up to 200%) in skeletal muscle mass, similar to those observed in Myostatin knockout mice. Recombinant Human Myostatin Propeptide is a 27.8 kDa protein consisting of 244 amino acid residues.
More Information
Size | 25 µg |
---|---|
Source | E. coli |
Biological Activity | Determined by its ability to neutralize the Myostatin inhibitory effect of murine MPC-11 cells. The expected ED50 is 0.01–0.04 μg/ml in the presence of 50 ng/ml Myostatin. |
Purity Confirmation | > 98% by SDS-PAGE & HPLC analyses |
Length [aa] | 244 |
Molecular Weight | 27.8 kDa |
Species Reactivity | Mouse |
Formulation | lyophilized |
Protein Sequence | MNENSEQKEN VEKEGLCNAC TWRQNTKSSR IEAIKIQILS KLRLETAPNI SKDVIRQLLP KAPPLRELID QYDVQRDDSS DGSLEDDDYH ATTETIITMP TESDFLMQVD GKPKCCFFKF SSKIQYNKVV KAQLWIYLRP VETPTTVFVQ ILRLIKPMKD GTRYTGIRSL KLDMNPGTGI WQSIDVKTVL QNWLKQPESN LGIEIKALDE NGHDLAVTFP GPGEDGLNPF LE |
Synonyms | MSTN; GDF8; MSLHP |
Uniprot ID | O14793 |
Protein RefSeq | NP_005250.1 |
mRNA RefSeq | NM_005259.2 |